Skip to main content
SpringerLink
Log in

Myocarditis and Cardiogenic Shock

  • Chapter
Book cover Cardiogenic Shock

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 168 Accesses

Abstract

Myocarditis is a nonischemic inflammatory or immunologic response of the myocardium. The inflammatory process may involve the myocytes, interstitium, cardiac vasculature, and the pericardium. Myocarditis has various causes, the most common being an infectious process. Diagnosing myocarditis and, more so, identifying the specific cause remain a challenge, especially when the course is subclinical, asymptomatic, or self-limiting. In rare cases, myocarditis may take a fulminant and malignant direction, leading to the rapid deterioration of cardiac function and, eventually, to cardiogenic shock. Unlike with extensive myocardial infarction, severe cardiac dysfunction resulting from myocarditis may be totally reversible. Hence, the use of specialized modalities to assist the failing heart until full recovery is of utmost importance. The aim of this chapter is to review the various modalities applied in patients with refractory heart failure resulting from myocarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. O’Connell JB, Renlund DG. Myocarditis and specific myocardial diseases. In: Schlant RC, Alexander RW, eds. Hurst’s The Heart. 8th ed. McGraw-Hill, New York, 1994, p. 1592.

    Google Scholar 

  2. Hyypia T. Etiological diagnosis of viral heart disease. Scand J Infect Dis 1993; 88 (Suppl): 25–31.

    CAS  Google Scholar 

  3. Hagar JM. Rahimtoola SH. Chagas’ heart disease in the United States. N Engl J Med 1991; 325: 763–768.

    Article  PubMed  CAS  Google Scholar 

  4. Matsumori A, Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 1982; 66: 355–360.

    Article  PubMed  CAS  Google Scholar 

  5. McManus BM, Chow LH, Wilson JE, et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993; 68: 159–169.

    Article  PubMed  CAS  Google Scholar 

  6. Woodruff JF. Viral myocarditis: a review. Am J Pathol 1980; 101: 425–484.

    PubMed  CAS  Google Scholar 

  7. Lodge PA, Herzum M, Olszewski J, Huber SA. Coxsackievirus B-3 myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanism. Am J Pathol 1987; 128: 455–463.

    PubMed  CAS  Google Scholar 

  8. Rose NR, Neumann DA, Herskowitz A. Coxsackievirus myocarditis. Adv Intern Med 1992; 37: 411–429.

    PubMed  CAS  Google Scholar 

  9. Myocarditis Treatment Trial Investigators. Incidence and clinical characteristics of myocarditis [abstract]. Circulation 1991; 84 (Suppl 2): II - 2.

    Google Scholar 

  10. Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000; 102: 2829–2835.

    Article  PubMed  CAS  Google Scholar 

  11. Karjalainen J. Functional and myocarditis-induced T-wave abnormalities. Effect of orthostasis beta-blockade, and epinephrine. Chest 1983; 83: 868–874.

    Google Scholar 

  12. Toshima H, Ohkita Y, Shingu M. Clinical features of acute coxsackie B viral myocarditis. Jpn Circ J 1979; 43: 441–444.

    Article  PubMed  CAS  Google Scholar 

  13. Granath A, Kimby AG, Sodemark T, Volpe U, Zetterquist S. Stokes-Adams attacks requiring pacemaker treatment in three patients with acute nonspecific myocarditis. Acta Med Scand 1980; 207: 177–181.

    Article  PubMed  CAS  Google Scholar 

  14. Costanzo-Nordin Mr, O’Connell JB, Subramanian R, Robinson JA, Scanlon PJ. Myocarditis confirmed by biopsy presenting as acute myocardial infarction. Br Heart J 1985; 53: 25–29.

    Google Scholar 

  15. Laurenceau JL, Cereze P, Dumesnil JG. Echocardiographic monitoring of myocarditis: detection of regional dysfunction. Coeur Med Interne 1979; 18: 451–459.

    PubMed  CAS  Google Scholar 

  16. Pinamonti B, Alberti E, Cigalotto A, et al. Echocardiographic findings in myocarditis. Am J Cardiol 1988; 62: 285–291.

    Article  PubMed  CAS  Google Scholar 

  17. Aryan S, Manalo E. Sudden increase in left ventricular mass secondary acute myocarditis. Am Heart J 1988; 116: 200–202.

    Article  Google Scholar 

  18. Acquatella H, Schiller NB. Echocardiographic recognition of Chagas disease and endomyocardial fibrosis. J Am Soc Echocardiogr 1988; 1: 60–68.

    PubMed  CAS  Google Scholar 

  19. Herskowitz A, Cambell S, Deckers J, et al. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 1993; 71: 982–986.

    Article  PubMed  CAS  Google Scholar 

  20. Starling RC, Van Fossen DB, Hammer DF, Unverferth DV. Morbidity of endomyocardial biopsy in cardiomyopathy. Am J Cardiol 1991; 68: 133–136.

    Article  PubMed  CAS  Google Scholar 

  21. Lewis AB, Neustein HB, Takahashi M, Lurie PR. Findings on endomyocardial biopsy in infants and children with dilated cardiomyopathy. Am J Cardiol 1985; 55: 143–145.

    Article  PubMed  CAS  Google Scholar 

  22. Wiles HB, Gilette PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic. J Am Coll Cardiol 1992; 20: 359–362.

    Article  PubMed  CAS  Google Scholar 

  23. Webber SA, Boyle GJ, Jaffe R, Pickering RM, Beerman LB, Fricker FJ. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis. Br Heart J 1994; 72: 360–363.

    Article  PubMed  CAS  Google Scholar 

  24. Sanderson JE, Koech D, Iha D, Ojiambo HP. T-Lymphocyte subsets in idiopathic dilated cardiomyopathy. Am J Cardiol 1985; 55: 755–758.

    Article  PubMed  CAS  Google Scholar 

  25. Caforio ALP, Stewart JT, Bonifacio E, et al. Inappropriate major histocompatability complex expression on cardiac tissue in dilated cardiomyopathy: relevance for autoimmunity? J Autoimmun 1990; 3: 187–200.

    Article  PubMed  CAS  Google Scholar 

  26. Caforio ALP, Goldman JH, Baig MK, et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997; 77: 62–67.

    PubMed  CAS  Google Scholar 

  27. Magnusson Y, Wallukat G, Waagstein E, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta 1-adrenoreceptor with positive chronotropic effect. Circulation 1994; 89: 2760–2767.

    Article  PubMed  CAS  Google Scholar 

  28. Podlowski S, Luther HP, Morwinski R, Muller J, Wallukar G. Agonistic anti-betal-adrenergic receptor expression autoantibodies from cardiomyopathy patients reduce the betal-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 1998; 98: 2470–2476.

    Article  PubMed  CAS  Google Scholar 

  29. Baig MK, Goldman JH, Caforio ALP, Coonar AS, Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998; 31: 195–201.

    Article  PubMed  CAS  Google Scholar 

  30. Feldman AM, McNamara DM. Medical Prognosis: myocarditis. N Engl J Med 2000; 343: 1388–1398.

    Article  PubMed  CAS  Google Scholar 

  31. Fenoglio JJ, Ursell PC, Kellogg CF, Drusin RE, Weiss MB. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 1983; 308: 12–18.

    Article  PubMed  Google Scholar 

  32. Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: longterm follow-up after circulatory support with left ventricular assist device. Am Heart J 1991; 121: 922–926.

    Article  PubMed  CAS  Google Scholar 

  33. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcomes. N Engl J Med 1985; 312: 885–890.

    Article  PubMed  Google Scholar 

  34. Saffitz JE, Schwartz DJ, Southworth W, et al. Coxsackie viral myocarditis causing transmural right and left ventricular infarction without coronary narrowing. Am J Cardiol 1983; 52: 644–647.

    Article  PubMed  CAS  Google Scholar 

  35. Burch GE, Shewey IL. Viral coronary arteritis and myocardial infarction. Am Heart J 1976; 92: 11–14.

    Article  PubMed  CAS  Google Scholar 

  36. Ferguson DW, Farwell AP, Bradley WA, Rollings RC. Coronary artery vasospasm complicating acute myocarditis. West J Med 1988; 148: 664–669.

    PubMed  CAS  Google Scholar 

  37. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 1986; 256: 2696–2699.

    Article  PubMed  CAS  Google Scholar 

  38. Cooper LT, Berry GJ, Rizeq M, Schroeder JS. Giant cell myocarditis. J Heart Lung Transplant 1995; 14: 394–401.

    PubMed  Google Scholar 

  39. Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol 1985; 6: 797–801.

    Article  PubMed  CAS  Google Scholar 

  40. Hanawa H, Kodama M, Inomata T, et al. Anti-alpha beta T cell receptor antibody prevents the prognosis of experimental autoimmune myocarditis. Clin Exp Immunol 1994; 96: 470–475.

    Article  PubMed  CAS  Google Scholar 

  41. Zhang S, Kodama M, Hanawa H, Izumi T, Shibata A, Masani F. Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 1993; 21: 1254–1260.

    Article  PubMed  CAS  Google Scholar 

  42. Desjardins V, Pelletier G, Leung TK, Waters D. Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis. Can J Cardiol 1992; 8: 788–792.

    PubMed  CAS  Google Scholar 

  43. Ren H, Poston RS Jr, Hruban RH, Baumgartner WA, Baughman KL, Hutchins GM. Long survival with giant cell myocarditis. Mod Pathol 1993; 6: 402–407.

    PubMed  CAS  Google Scholar 

  44. Kong G, Madden B, Spyrou N, Pomerance A, Mitchell A, Yacoub M. Response of recurrence giant cell myocarditis in a transplanted heart to intensive immunosuppression. Eur Heart J 1991; 12: 554–557.

    PubMed  CAS  Google Scholar 

  45. Gries W, Farkas D, Winters GL, Constanzo-Nordin MR. Giant cell myocarditis: first report of disease recurrent in the transplanted heart. J Heart Lung Transplant 1992; 11: 370–374.

    PubMed  CAS  Google Scholar 

  46. Grant SC. Giant cell myocarditis in a transplanted heart. Eur Heart J 1993; 14: 1437.

    Article  PubMed  CAS  Google Scholar 

  47. Cooper DK, Schlesinger RG, Shrago S, Zuhdi N. Heart transplantation for giant cell myocarditis. J Heart Lung Transplant 1994; 13: 555.

    PubMed  CAS  Google Scholar 

  48. Cooper LT jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860–1866.

    Google Scholar 

  49. Matsumori A, Igata H, Ono K, et al. High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity. Jpn Circ J 1999; 63: 934–940.

    Article  PubMed  CAS  Google Scholar 

  50. McCormack JG, Bowler SD, Donnelly JE, Steadman C. Successful treatment of severe cytomegalovirus infection with ganciclovir in immunocompetent host. Clin Infect Dis 1998; 26: 1007–1008.

    Article  PubMed  CAS  Google Scholar 

  51. Baykurt C, Caglar K, Ceviz N, Akyuz C, Secmeer G. Successful treatment of Epstein-Barr virus infection associated with myocarditis. Pediatr Int 1999; 41: 389–391.

    Article  PubMed  CAS  Google Scholar 

  52. Maisch B, Hufnagel G, Schonian U, Hengstenberg C. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J 1995; 16 (Suppl O): 173–175.

    Article  PubMed  Google Scholar 

  53. Mason JW, O’Connell JB, Herskowitz A, et al. and the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269–275.

    Google Scholar 

  54. Dec GW, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885–890.

    Article  PubMed  Google Scholar 

  55. McNamara DM, Starling RC, Dec GW, et al. Intervention in myocarditis and acute cardiomyopathy with immune globulin: results from the Randomized Placebo Controlled IMAC Trial [abstract]. Circulation 1999; 100 (Suppl I): I - 21.

    Google Scholar 

  56. McNamara DM, Rosenblum WD, Janosko, et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997; 95: 2467–2468.

    Google Scholar 

  57. Hetzer R, Henning E, Schiessler A, Friedel N, Warnecke H, Adt M. Mechanical circulatory support and heart transplantation. J Heart Lung Transplant 1992; 11: S175 - S181.

    PubMed  CAS  Google Scholar 

  58. Ueno T, Bergin P, Richardson M, Esmore DS. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis. Ann Thorac Surg 2000; 69: 284–286.

    Article  PubMed  CAS  Google Scholar 

  59. Rockman HA, Adamson RM, Denbitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: longterm follow-up after circulatory support with left ventricular assist device. Am Heart J 1991; 121: 922–926.

    Article  PubMed  CAS  Google Scholar 

  60. Chang AC, Hanley FL, Weindling SN, Wernovsky G, Wessel DL. Left heart support with a ventricular assist device in an infant with acute myocarditis. Crit Care Med 1992; 20: 712–715.

    Article  PubMed  CAS  Google Scholar 

  61. Holman WL, Bourge RC, Kirklin JK. Case report: circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg 1991; 102: 932–934.

    PubMed  CAS  Google Scholar 

  62. Farrar D, Hill JD, Pennington DG, McBride LR, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997; 113: 202–209.

    Article  PubMed  CAS  Google Scholar 

  63. Uneo T, Bergin P, Richardson M, Esmore DS. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis. Ann Thorac Surg 2000; 69: 284–286.

    Article  Google Scholar 

  64. Kato S, Morimoto SI, Hiramitsu S, Nomura M, Ito T, Hishida H. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 1999; 83: 623–625.

    Article  PubMed  CAS  Google Scholar 

  65. Bartlett RH. Extracorporeal life support for cardiopulmonary failure. Curr Probl Surg 1990; 27: 623–705.

    Article  Google Scholar 

  66. Bavaria JE, Furukawa S, Kreiner G, Gupta KB, Streicher J, Edmunds LH. Effect of circulatory assist devices on stunned myocardium. Ann Thorac Surg 1990; 49: 123–128.

    Article  PubMed  CAS  Google Scholar 

  67. Martin GR, Short BL. Doppler echocardiographic evaluation of cardiac performance in infants on prolonged extracorporeal membrane oxygenation. Am J Cardiol 1988; 62: 929–934.

    Article  PubMed  CAS  Google Scholar 

  68. Bavaria JE, Ratcliffe MB, Gupta KB, Wenger RK, Bogen DK, Edmunds LH. Changes in left ventricular systolic wall stress during biventricular circulatory assistance. Ann Thorac Surg 1988; 45: 526–532.

    Article  PubMed  CAS  Google Scholar 

  69. Kawahito K, Murata SI, Yasu T, et al. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol 1998; 82: 910–911.

    Article  PubMed  CAS  Google Scholar 

  70. Cofer BR, Warner BW, Stallion A, Ryckman FC. Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditis. J Pediatr Surg 1993; 28: 669–672.

    Article  PubMed  CAS  Google Scholar 

  71. Chen YS, Wang MJ, Chou NK, et al. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg 1999; 68: 2220–2224.

    Article  PubMed  CAS  Google Scholar 

  72. Yasu T, Murata S, Katsuki T, et al. Acutely severe myocarditis successfully treated by percutaneous cardiopulmonary support applied by a newly developed heparin-binding oxygenator and circuits. Jpn Circ J 1997; 61: 1037–1042.

    Article  PubMed  CAS  Google Scholar 

  73. Tsuboi H, Sone T, Sassa H, et al. Rescue of a patient with fulminant myocarditis by percutaneous extracorporeal bypass. Jpn J Med 1990; 29: 519–522.

    Article  PubMed  CAS  Google Scholar 

  74. Morishima I, Sassa H, Sone T, Tsuboi H, Kondo J, Koyama T. A case of fulminant myocarditis rescued by long-term percutaneous cardiopulmonary support. Jpn Circ J 1994; 58: 433–438.

    Article  PubMed  CAS  Google Scholar 

  75. Parisi F, Carotti A, Esu F, Abbattista AD, Cicini MP, Squitieri C. Intermediate and long-term results after pediatric heart transplantation: incidence and role of pretransplant diagnosis. Transplant Int 1998;1 1(Suppl 1 ): 5493 - S498.

    Google Scholar 

  76. Calabrese F, Valente M, Thiene G, et al. Enteroviral genome in native hearts may influence outcome of patients who undergo cardiac transplantation. Diagn Mol Pathol 1999; 8: 39–46.

    Article  PubMed  CAS  Google Scholar 

  77. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institute of Health) workshop recommendations and review. JAMA 2000; 283: 1183–1188.

    Article  PubMed  CAS  Google Scholar 

  78. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obster Gynecol 1999; 94: 311–316.

    Article  CAS  Google Scholar 

  79. Ventura SJ, Peters KD, Martin JA, Maurer JD. Births and deaths: United States, 1996. Mon Vital Stat Rep 1997;46(Suppl 2).

    Google Scholar 

  80. Aziz TM, Burgess MI, Acladious NN, et al. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review. Cardiovasc Surg 1999; 7: 565–567.

    Article  PubMed  CAS  Google Scholar 

  81. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342; 1077–1084.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Mordehay Vaturi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Hasdai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Battler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tel-Aviv University, Tel Aviv, Israel

    David Hasdai MD  & Alexander Battler MD  & 

  2. Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel

    Alexander Battler MD

  3. Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    Peter B. Berger MD  & David R. Holmes Jr. MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Vaturi, M., Hasdai, D., Battler, A. (2002). Myocarditis and Cardiogenic Shock. In: Hasdai, D., Berger, P.B., Battler, A., Holmes, D.R. (eds) Cardiogenic Shock. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-154-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-154-1_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-312-1

  • Online ISBN: 978-1-59259-154-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation